Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.21 - $2.22 $399 - $732
330 Added 2.03%
16,571 $21,000
Q4 2022

Feb 10, 2023

SELL
$0.85 - $1.69 $50 - $99
-59 Reduced 0.36%
16,241 $27,000
Q3 2022

Nov 14, 2022

BUY
$2.14 - $3.7 $6,501 - $11,240
3,038 Added 22.91%
16,300 $30,000
Q2 2022

Aug 12, 2022

BUY
$2.84 - $8.57 $37,664 - $113,655
13,262 New
13,262 $41,000

Others Institutions Holding PRDS

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.